Biocon Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BIOCON.BO | 1548.HK | 005250.KS | ANTHEM.NS | 085660.KQ | 3759.HK | |
|---|---|---|---|---|---|---|
| Market cap | 591.88B | 76.81B | 438.13B | 514.81B | 677.77B | 55.85B |
| P/E (TTM) | 121.3 | — | — | 84.4 | — | 27.4 |
| Forward P/E | 33.2 | 85.8 | — | 60.4 | — | 17.2 |
| Price/book | 1.7 | 2.4 | — | 15.7 | — | 2.8 |
| Dividend yield | 0.15% | — | 3.14% | 0.23% | — | 0.78% |
| 1-year change | −10.65% | +109.10% | −39.90% | +27.52% | −45.74% | +19.72% |
| Today | +5.06% | −0.94% | +1.47% | +2.84% | +5.96% | +3.47% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All BIOCON.BO news ›F&O Build-up November 3: 93 Stocks Show Long Signals; SBI, Biocon Lead Short Build-up
The Nifty 50 gained 370 points to close at 23,810.85 on Tuesday. NiftyTrader’s F&O snapshot identified 93 Long Build-up and 44 Short Build-up stocks across 218 individual F&O stocks, while the expiring Nifty weekly series recorded a…
Biocon Expands Janssen Settlement/Licence for Biosimilar Ustekinumab
Home / News / BioBlast® Biocon first launched Yesintek™ in the US in February 2025 (in PFS and vial presentations), following Yesintek™’s original FDA approval in November 2024. The timing of Biocon’s US launch was governed by a US…
CBI Court Discharges Former CDSCO Official in 2022 Biocon Biologics Bribery Case
New Delhi: A special Central Bureau of Investigation (CBI) court at Rouse Avenue in Delhi has discharged former Joint Drugs Controller Dr S. Eswara Reddy and three others in the 2022 Biocon Biologics bribery case, observing that the…
Failure is temporary, but giving up is final: Biocon’s Kiran Mazumdar-Shaw’s advice to executives
Q: You started Biocon at 25, at a time when being young and a woman made it harder to be taken seriously. What did you do in those early years to build credibility and earn trust, and what can young women managers learn from that? Q: What…
Best 3 stocks to buy: SBI, Britannia, Biocon by Ganesh Dongre of Anand Rathi | Targets, stop-loss, stock market views
The Pharma sector emerged as the top performer, rallying nearly 7% during the week. However, despite the recovery in domestic equities, Brent crude oil remains elevated, hovering in the $110–$115 per barrel range, keeping inflationary…
CBI court discharges former joint drugs controller in 2022 Biocon bribery base
A special Central Bureau of Investigation (CBI) court at Rouse Avenue on Saturday discharged Dr. S. Eswara Reddy, former joint drugs controller at the Central Drugs Standard Control Organisation (CDSCO), and three others in a 2022 bribery…
Biocon Secures Market Entry for Yesintek™, a Proposed Biosimilar to Stelara®, in Additional Global Markets
26 Oct 2026, 08:52 AM IST Equity Bulls Stock Report Biocon Limited INE376G01013 This milestone builds on the Company’s previously announced agreements with Janssen that secured market entry dates for Yesintek™ in the United States, and in…
Biocon recognised as top employer in global biotech and pharma for 2026
Read the Biocon Limited announcement filed with the NSE, with the key figures and what it means for shareholders. Biocon Limited, a prominent biopharmaceutical company headquartered in Bengaluru, India, has been ranked 13th among the top…
Biocon secures Yesintek biosimilar rights in nine markets
Biocon has signed a licence agreement with Janssen Sciences Ireland to enable the commercialisation of Yesintek, its proposed biosimilar to Stelara (ustekinumab), in Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South…
Electrical Products Maker Biocon Electric Limited Files DRHP with SEBI for IPO of up to 59,00,000 Equity Shares; Proposes Listing on the Main Board of BSE Limited and National Stock Exchange of India Limited
Bengaluru (Karnataka) [India], October 7: Biocon Electric Limited (“the Company”), a multi-category electrical products company selling under the “BIOCON” brand, has filed its Draft Red Herring Prospectus (DRHP) with SEBI for an initial…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com8
- medicaldialogues.in4
- tradingview.com4
- equitybulls.com2
- expresspharma.in2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 44 articles, not a forecast.